A Phase I study of NLG919 for adult patients with recurrent advanced solid tumors

Por Nayak, Asha, Hao, Zhonglin, Sadek, Ramses, Vahanian, Nicholas, Ramsey, W Jay, Kennedy, Eugene, Mautino, Mario, Link, Charles, Bourbo, Pamela, Dobbins, Robin, Adams, Kelly, Diamond, Allison, Marshall, Lisa, Munn, David H, Janik, John, Khleif, Samir N
Publicado no J Immunother Cancer (2014)

Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors

Por Nayak-Kapoor, Asha, Hao, Zhonglin, Sadek, Ramses, Dobbins, Robin, Marshall, Lisa, Vahanian, Nicholas N., Jay Ramsey, W., Kennedy, Eugene, Mautino, Mario R., Link, Charles J., Lin, Ray S., Royer-Joo, Stephanie, Liang, Xiaorong, Salphati, Laurent, Morrissey, Kari M., Mahrus, Sami, McCall, Bruce, Pirzkall, Andrea, Munn, David H., Janik, John E., Khleif, Samir N.
Publicado no J Immunother Cancer (2018)